NCT02745457

Brief Summary

Background: Growth impairment is commonly seen in children diagnosed with inflammatory bowel diseases (IBD), mainly those with Crohn's disease (CD). There is general consensus in the literature that body composition, composed of fat mass and lean mass is altered in children with IBD compared with controls. Evidence regarding the effect of different therapeutic approaches on body composition in children with IBD is scarce and inconsistent. Furthermore, most studies used anthropometric measures and dual energy X-ray absorptiometry (DEXA) for body composition assessment, while information on the usefulness of air displacement plethysmography (ADP) for this assessment is lacking. Objectives: To assess body composition in children with IBD by ADP and DEXA at diagnosis and at various intervals during follow up. Design: A prospective cohort study. Setting: Pediatric gastroenterology institute, Schneider Children's Hospital. Participants: Children 6 year to 17 years who are diagnosed with either CD or ulcerative colitis (UC). Main outcome measures: Accuracy of ADP in comparison to DEXA and percentage of fat mass and lean mass at diagnosis and during treatment. Secondary outcome measures: Correlation of body composition to skin fold, mid arm circumference measurements, BMI, inflammatory markers, gender, disease activity and physical activity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

April 13, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 20, 2016

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
Last Updated

November 22, 2023

Status Verified

November 1, 2023

Enrollment Period

5.4 years

First QC Date

April 13, 2016

Last Update Submit

November 20, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • To evaluate the change in body composition accorging to treatment treatment is children with IBD over the course of 2 years

    Percentage of fat mass and lean mass at diagnosis and during treatment

    24 months

Secondary Outcomes (5)

  • To assess the accuracy of ADP in comparison to DEXA based measurement of body composition in children with IBD

    24 months

  • To evaluate the correlation of body composition to skin fold and mid arm circumference measurements in children with IBD

    24 months

  • To evaluate the correlation of body composition with BMI

    24 months

  • To evaluate the correlation of body composition with disease activity

    24 months

  • To evaluate the correlation of body composition with physical activity

    24 months

Eligibility Criteria

Age6 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Children at age 6 year to 17 years diagnosed with IBD

You may qualify if:

  • Diagnosis of IBD
  • Age: 6 - 17 years ( inclusive)
  • Informed consent

You may not qualify if:

  • Pregnancy
  • Non IBD associated chronic diseases
  • Morbid obesity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Schenider Children's Medical Center

Petah Tikva, 4920235, Israel

Location

MeSH Terms

Conditions

Crohn DiseaseColitis, Ulcerative

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesColitisColonic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of IBD program

Study Record Dates

First Submitted

April 13, 2016

First Posted

April 20, 2016

Study Start

April 1, 2016

Primary Completion

September 1, 2021

Study Completion

July 31, 2023

Last Updated

November 22, 2023

Record last verified: 2023-11

Locations